4.6 Article

Restoration of CD4+ T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression

Lorenzo A. Orci et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) may be a risk factor for hepatocellular carcinoma (HCC), and this study used meta-analysis to analyze the incidence rates of HCC in NAFLD patients. The results showed that NAFLD patients with cirrhosis have a similar risk of developing HCC compared to cirrhosis patients with other causes. However, the incidence of HCC in nonalcoholic steatohepatitis or simple steatosis patients is lower.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Oncology

Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways

Masoud H. Manjili et al.

Summary: This thematic issue discusses the mechanisms of tumor dormancy and relapse, highlighting the interactions between malignant cells and other cells in their microenvironment during dormancy. However, a complete understanding of tumor dormancy remains challenging. To discover the pattern of tumor dormancy and relapse, exploring conceptual frameworks and methodological approaches, and focusing on specific biological scales such as mitochondria, are proposed.

SEMINARS IN CANCER BIOLOGY (2022)

Article Cell Biology

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma

Faridoddin Mirshahi et al.

Summary: Distinct immune responses promoting or inhibiting hepatocellular carcinoma (HCC) in a gender-specific manner were discovered through three-dimensional analysis of immune cells in an animal model of NAFLD-associated HCC. Tumor progression in males and females is associated with different immune cell patterns and interactions in the liver.

CELL REPORTS (2022)

Review Immunology

CD4+ T cell activation and inflammation in NASH-related fibrosis

Yunfeng Zhou et al.

Summary: Liver fibrosis is a life-threatening disease worldwide, with nonalcoholic fatty liver disease (NAFLD) being a major cause, and immune response and inflammation playing important roles in the development and progression of NASH.

FRONTIERS IN IMMUNOLOGY (2022)

Review Biotechnology & Applied Microbiology

Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms

Rong En Tay et al.

Summary: Cancer immunotherapy has transformed cancer treatment, with immune checkpoint blockade therapy and adoptive cell therapy becoming standard care for many cancer types. Recent evidence suggests that CD4(+)T cells play a significant role in the anti-tumour immune response, highlighting their potential importance in cancer immunotherapies.

CANCER GENE THERAPY (2021)

Article Multidisciplinary Sciences

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers

George F. Wohlford et al.

Summary: SP16 treatment up to doses of 0.2 mg/kg or 12 mg was safe in healthy volunteers, with no treatment-related serious adverse events observed. Mild-moderate pain at the time of injection was associated with SP16 compared to placebo, but no differences were found in vital signs, laboratory examinations, and electrocardiography between the two groups.

PLOS ONE (2021)

Review Gastroenterology & Hepatology

Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets

Yoon Mee Yang et al.

SEMINARS IN LIVER DISEASE (2019)

Review Cardiac & Cardiovascular Systems

Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing

Nicola Potere et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)

Article Cell Biology

Gr1(-/low)CD11b(-/low)MHCII(+) myeloid cells boost T cell anti-tumor efficacy

Kyle K. Payne et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2018)

Review Immunology

CD4+ T cell help in cancer immunology and immunotherapy

Jannie Borst et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Gastroenterology & Hepatology

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Amon Asgharpour et al.

JOURNAL OF HEPATOLOGY (2016)

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)